Biosimilar buffer? EU thumbs up for Amgen's Neulasta delivery device
The EMA has recommended approval of Amgen’s on-body injector device to be used with its biosimilar-threatened Neulasta (pegfilgrastim).
Archives for March 7, 2018
Cryoport ups cold chain presence on regenerative med potential
Cryoport will open two global centres and has inked a deal with McKesson to support the growth in demand for cell and gene therapy logistics.
Beyond mammalian culture: ABEC’s single-use range to cover microbial fermentation
Bioprocessing vendor ABEC has added microbial fermentation capabilities to its single-use line.